It’s estimated that about six million people in the U.S. have the dreaded form of dementia known as Alzheimer’s disease. The search for a cure has fallen frustratingly short. Now, one pharmaceutical company says a cure, at least for early Alzheimer’s, is on the horizon— just waiting for FDA approval. But it’s not so simple. Today’s cover story: questions about conflicts of interest, money, and why critics say it’s a Mind Game. --------- Full Measure is a weekly Sunday news program focusing on investigative, original and accountability reporting. The host is Sharyl Attkisson, five-time Emmy Award winner and recipient of the Edward R. Murrow award for investigative reporting. She is backed by a team of award winning journalists. Each week, we have a cover story that explores untouchable topics in a fearless way including: immigration, terrorism, government waste, national security and whistleblower reports on government and corporate abuse and misdeeds. Full Measure is broadcast to 43 million households in 79 markets on 162 Sinclair Broadcast Group stations, including ABC, CBS, NBC, FOX, CW, MyTV, Univision and Telemundo affiliates. It also streams live Sunday mornings at 9:30 a.m. ET. Read more about us at: http://fullmeasure.news/about Find out where to watch us at: http://fullmeasure.news/about Like us on Facebook: https://www.facebook.com/FullMeasureNews Follow us on Twitter: https://twitter.com/FullMeasureNews This video and all Sinclair Broadcast Group content archives of local news and sports coverage are available for your use. For more information contact us at contentsales@sbgtv.com
